medicalnewstoday.com/amp/ar...
A new study suggests that repurposing glycolysis-enhancing drugs such as terazosin, which is typically used to treat an enlarged prostate, may reduce the risk of Parkinson’s disease in men.
medicalnewstoday.com/amp/ar...
A new study suggests that repurposing glycolysis-enhancing drugs such as terazosin, which is typically used to treat an enlarged prostate, may reduce the risk of Parkinson’s disease in men.
This isn't limited to terazosin, but I wonder if drugs which purportedly prevent Parkinson’s are also effective at slowing or stopping progression in those of us who already have it.